Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT00289380
Recruiting Observational

Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk

NCT00289380 · tracked via the Priya Life Science China tracker
Sponsor
Peking Union Medical College
Phase
Observational
Started
2005-01
Last updated
2026-01-09

Condition(s) studied

MalnutritionNutritional Risk

Study summary

1. The aim of this large scale study to survey the prevalence of nutritional risk and malnutrition in China,Europe and USA.
2. The impact of nutritional support for the patients at nutritional risk on clinical outcomes and cost-effectiveness

Already get the approval by Ethics Committee of Peking Union medical college and Johns Hopkins Hospital.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * patients be in hospital overnight * diagnoses according to the protocol of cohort study for cost effectiveness Exclusion Criteria: * patients admitting from emergency department * patients who undergone operation before second morning of hospitalization * patients who dose not give Informed Consents

Primary outcome measure(s)

  • Infectious complication — Observation will be carried from admitting end until discharge
    A infectious complication was defined as as the presence of recognized pathogens in body tissues that normally are sterile, confirmed by the results of culture and supported by clinical, radiologic or hematologic evidence of infection

Trial sites (15)

FacilityCityRegionStatus
Beijing Friendship Hospital, Capital Medical University Beijing Beijing Municipality Active Not Recruiting
Peking Union Medical College Hospital Beijing Beijing Municipality Active Not Recruiting
Beijing Chest Hospital, Capital Medical University Beijing Beijing Municipality Not Yet Recruiting
Chongqing Medical Univ. Hospital Chongqing Chongqing Municipality Completed
Xin Qiao Hospital Chongqing Chongqing Municipality Recruiting
The First Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong Recruiting
The First Affiliated Hospial, Guangxi Medical University Nanning Guangxi Recruiting
The First University Hospital, Hebei Medical University Shijiazhuang Hebei Recruiting
Nankai Hospital Tianjin Hebei Active Not Recruiting
Tongji Hospital, Huazhong University of Science and Technology Wuhan Hubei Recruiting
Nanjing General Hospital of Nanjing Military Command Nanjing Jiangsu Recruiting
Xin Hua Hospital, Shanghai Jiaotong University Shanghai Shanghai Municipality Recruiting
Sixth Hospital Shanghai Shanghai Municipality Recruiting
The First Affiliated Hospital, Xinjiang Medical University Ürümqi Xinjiang Active Not Recruiting
Second Affiliated Hospital, Zhejiang University Hangzhou Zhejiang Active Not Recruiting

More Peking Union Medical College trials in China

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing Recruiting
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway Starting soon
Tooth and Bone-borne Cutting/Repositioning Guide and Patient-specific Implant(PSI) Recruiting
Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning Recruiting
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa Recruiting

Other trials for the same condition

Washed Microbiota Transplantation for Malnutrition Recruiting
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT Active, not recruiting
Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk Starting soon
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy Starting soon
Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00289380 on ClinicalTrials.gov ↗ ← All trials in China